ZS801

GENETIC2 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China

Conditions

Hemophilia B

Phase 1

A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

RecruitingNCT05641610

Institute of Hematology & Blood Diseases Hospital, ChinaHemophilia B

Start: 2022-02-16End: 2028-12-31Target: 21Updated: 2025-02-24

Unknown Phase

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

RecruitingNCT05630651

Institute of Hematology & Blood Diseases Hospital, ChinaHemophilia B

Start: 2023-04-19End: 2028-12-31Target: 6Updated: 2025-02-24